Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.7B |
| FY2017, ended Dec 30, 2017 | $9.96B |
| FY2018, ended Dec 29, 2018 | $17.9B |
| FY2019, ended Dec 28, 2019 | $54.0B |
| FY2020, ended Dec 26, 2020 | $111B |
| FY2021, ended Dec 25, 2021 | $175B |
| FY2022, ended Dec 31, 2022 | $104B |
| FY2023, ended Dec 30, 2023 | $238B |
| FY2024, ended Dec 28, 2024 | $203B |
| FY2025, ended Dec 27, 2025 | $351B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $851B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.32B |
| FY2017, ended Dec 30, 2017 | $5.33B |
| FY2018, ended Dec 29, 2018 | $6.47B |
| FY2019, ended Dec 28, 2019 | $6.73B |
| FY2020, ended Dec 26, 2020 | $9.76B |
| FY2021, ended Dec 25, 2021 | $16.4B |
| FY2022, ended Dec 31, 2022 | $23.6B |
| FY2023, ended Dec 30, 2023 | $22.7B |
| FY2024, ended Dec 28, 2024 | $25.8B |
| FY2025, ended Dec 27, 2025 | $34.6B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $41.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$498M | $4.00M |
| FY2017, ended Dec 30, 2017 | −$33.0M | −$101M |
| FY2018, ended Dec 29, 2018 | $337M | −$129M |
| FY2019, ended Dec 28, 2019 | $341M | $276M |
| FY2020, ended Dec 26, 2020 | $2.49B | $777M |
| FY2021, ended Dec 25, 2021 | $3.16B | $3.22B |
| FY2022, ended Dec 31, 2022 | $1.32B | $3.12B |
| FY2023, ended Dec 30, 2023 | $854M | $1.12B |
| FY2024, ended Dec 28, 2024 | $1.64B | $2.40B |
| FY2025, ended Dec 27, 2025 | $4.33B | $6.74B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $6.43B | $8.40B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.26B |
| FY2017, ended Dec 30, 2017 | $1.19B |
| FY2018, ended Dec 29, 2018 | $1.08B |
| FY2019, ended Dec 28, 2019 | $1.47B |
| FY2020, ended Dec 26, 2020 | $1.59B |
| FY2021, ended Dec 25, 2021 | $2.54B |
| FY2022, ended Dec 31, 2022 | $4.83B |
| FY2023, ended Dec 30, 2023 | $3.93B |
| FY2024, ended Dec 28, 2024 | $3.79B |
| FY2025, ended Dec 27, 2025 | $5.54B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $5.09B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.44B |
| FY2017, ended Dec 30, 2017 | $1.40B |
| FY2018, ended Dec 29, 2018 | $1.25B |
| FY2019, ended Dec 28, 2019 | $486M |
| FY2020, ended Dec 26, 2020 | $330M |
| FY2021, ended Dec 25, 2021 | $313M |
| FY2022, ended Dec 31, 2022 | $2.47B |
| FY2023, ended Dec 30, 2023 | $3.22B |
| FY2024, ended Dec 28, 2024 | $1.72B |
| FY2025, ended Dec 27, 2025 | $4.10B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $3.23B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 73.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 941M |
| FY2017, ended Dec 30, 2017 | 969M |
| FY2018, ended Dec 29, 2018 | 1.01B |
| FY2019, ended Dec 28, 2019 | 1.17B |
| FY2020, ended Dec 26, 2020 | 1.21B |
| FY2021, ended Dec 25, 2021 | 1.20B |
| FY2022, ended Dec 31, 2022 | 1.61B |
| FY2023, ended Dec 30, 2023 | 1.62B |
| FY2024, ended Dec 28, 2024 | 1.62B |
| FY2025, ended Dec 27, 2025 | 1.63B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | 1.63B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $86.0M | $667M |
| FY2017, ended Dec 30, 2017 | — | $97.0M | $0 |
| FY2018, ended Dec 29, 2018 | — | $137M | $0 |
| FY2019, ended Dec 28, 2019 | $0 | $197M | — |
| FY2020, ended Dec 26, 2020 | $0 | $274M | — |
| FY2021, ended Dec 25, 2021 | $1.76B | $379M | — |
| FY2022, ended Dec 31, 2022 | $3.70B | $1.08B | — |
| FY2023, ended Dec 30, 2023 | $985M | $1.38B | — |
| FY2024, ended Dec 28, 2024 | $862M | $1.41B | — |
| FY2025, ended Dec 27, 2025 | $1.32B | $1.64B | — |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $310M | $1.90B | — |
Valuation
At current price- Market Cap
- $915B
- P/E
- 142×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 22.1×
- Price / Book
- 13.6×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $41.3B
- Revenue Growth YoY
- 39.5%
- Revenue CAGR 3Y
- 13.6%
- Revenue CAGR 5Y
- 28.8%
- EPS Growth YoY
- 125%
- Net Income Growth YoY
- 127%
Profitability
Trailing 12 months- Gross Margin
- 53.2%
- Operating Margin
- 15.7%
- Net Margin
- 15.6%
- FCF Margin
- 20.3%
- Return on Equity
- 10.1%
Earnings
Trailing 12 months- Net Income
- $6.43B
- EPS (diluted)
- $3.90
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $6.49B
Balance Sheet
As of Jun 27, 2026- Cash and cash equivalents
- $5.09B
- Total Debt
- $3.23B
- Net Cash
- $1.86B
- Total Assets
- $84.5B
- Total Liabilities
- $17.2B
- Shareholders' Equity
- $67.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.1B
- Capital Expenditure
- $1.68B
- Free Cash Flow
- $8.40B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 2.45
Every ratio is calculated from the company’s reported figures.